The pharmaceutical industry is sizable, with the US commanding the largest slice of the market. But competition within the sector is cutthroat and regulatory approval is an ongoing hurdle.
What are pharmaceutical stocks?
Pharmaceutical stocks are stocks from companies that research and produce pharmaceutical drugs and medical equipment.
The industry is dominated by big names like Pfizer, Johnson & Johnson and GlaxoSmithKline — famous for blockbuster drugs netting over $1 billion in annual sales, like Advair, Lipitor and Zoloft.
But there are numerous up-and-comers in the industry offering a spectrum of entry points for investors, like livestock medicine manufacturer Zoetis or Neoleukin Therapeutics, a biopharmaceutical company that targets immunological disorders.
Why invest in pharmaceutical stocks?
The global pharmaceutical industry is massive — and the US holds the largest slice of the market. In 2018, worldwide pharmaceutical revenue sat at $1.2 trillion, with the US commanding a 40.4% share of the market with pharmaceutical sales of $484.5 billion.
According to Statista, the US also happens to have some of the highest prescription drug prices in the world — bad news for the general public but profitable for well-established drug companies like Pfizer and its shareholders.
Pharma stocks also have the potential to outperform the broader market. For example, the SPDR S&P Pharmaceuticals ETF has outperformed the S&P 500 since its 2006 inception.
And if the potential for profit isn’t incentive enough, investors also have the opportunity to back potentially groundbreaking, life-saving medicine — medicine that they or a loved one may one day rely on.
Risks of investing in pharmaceuticals
Pharmaceutical stocks present a potentially lucrative investment opportunity but carry significant risks, including competition from generic drugmakers, product patent expirations and the substantial cost of research and development (R&D).
It’s estimated that pharmaceutical companies spend approximately 20% of their revenue on research and development. In fact, in 2018, US companies spent a collective $80 billion on R&D, according to Statista. What makes this expense especially unpalatable is the risk drug companies face in having their products rejected by regulatory authorities like the US Food and Drug Association (FDA). A company could spend millions researching and developing a product, only to have it rejected by the FDA.
Pharma companies also face steep competition from generic drugmakers attempting to undercut brand-name products with cheaper alternatives — especially for drugs with patent expirations on the horizon.
The industry is far from foolproof, and while pharma stocks could be a potentially profitable addition to your portfolio, make sure you understand the risks involved before you invest.
How has COVID-19 affected pharmaceutical stocks?
In the wake of the coronavirus pandemic, pharmaceutical companies have been thrust into the global spotlight as over 155 vaccine candidates scramble for regulatory clearance. Many of the big-name drug manufacturers with COVID-19 vaccines in trials have seen their stock prices rise alongside press releases of potential efficacy rates, including Pfizer, Moderna and AstraZeneca. These so-called COVID stocks may continue to see market growth, but the gains related to the pandemic may be short-lived.
There’s money to be made from selling a COVID-19 vaccine, but analysts warn that as more drug companies enter late-stage trials, the number of viable vaccine candidates will grow and no single manufacturer will be able to monopolize vaccine sales.
These pharmaceutical stocks hail from companies headquartered in the US and around the globe. Select a company to learn more about what they do and how their stock performs, including market capitalization, the price-to-earnings (P/E) ratio, price/earnings-to-growth (PEG) ratio and dividend yield. While this list includes a selection of the most well-known and popular stocks, it doesn't include every stock available.
What ETFs track the pharmaceutical category?
Pharmaceutical ETFs contain baskets of stocks from a range of businesses within the industry, including pharmaceutical companies, medical device manufacturers and more.
- Invesco Dynamic Pharmaceuticals ETF (PJP)
- iShares U.S. Pharmaceuticals ETF (IHE)
- KraneShares MSCI All China Health Care Index ETF (KURE)
- SPDR S&P Pharmaceuticals ETF (XPH)
- VanEck Vectors Pharmaceutical ETF (PPH)
Compare trading platforms
To invest, you’ll need a brokerage account. Explore your options below.
*Signup bonus information updated weekly.
Pharma stocks offer investors the opportunity to back groundbreaking drug research, but competition in this industry has the potential to threaten profits.
To invest in pharmaceutical companies, you’ll need a brokerage account. Compare your platform options to find the brokerage that fits your budget and investment goals needs.
More guides on Finder
3 upcoming IPOs to watch in August 2021
Keep an eye on these upcoming IPOs in August 2021.
What is an ADR stock?
A way to invest in foreign companies on US stock exchanges.
Vanguard Digital Advisor review
Features and feedback to consider before you sign up for Vanguard Digital Advisor.
A beginner’s guide to retirement investing
What you need to know to start building your retirement nest egg.
Best Roth IRA accounts of 2021
These Roth IRAs stand out for their competitive fees, intuitive platforms and practical research tools.
9 best growth ETFs
Invest in growth ETFs to access companies with high growth potential.
Investing strategies: How income stocks make you money
Earn passive income with the right investment.
Best IRA accounts of 2021
Check out the best IRAs with the lowest fees and the most useful features.
Investing strategies: Contrarian investing
Contrarian investing can help you profit by going against the herd. Learn more.
Investing for kids: Get started the right way
Custodial brokerage accounts for kids — because it’s never too early to start saving and investing.
Ask an Expert